Cubist Pharmaceuticals Acquires Calixa Therapeutics for $92,500,000

  • Feed Type
  • Date
    12/14/2009
  • Company Name
    Calixa Therapeutics
  • Mailing Address
    12481 High Bluff Drive San Diego, CA 92130
  • Company Description
    Calixa Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of a novel cephalosporin to address the expanding problem of multi-drug resistant organisms. Treatment of infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa, is recognized as an unmet medical need by the infectious diseases community.
  • Website
    http://www.calixainc.com
  • Transaction Type
    M&A
  • Transaction Amount
    $92,500,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The deal includes a $92.5 up-front cash payment, plus up to $310 million in earnout payments.